{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:09:20Z","timestamp":1775192960854,"version":"3.50.1"},"reference-count":17,"publisher":"Practical Medicine Publishing House","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Oncohematology"],"abstract":"<jats:p>Background &amp; Aims.\u00a0Lactate dehydrogenase (LDH) and b2-microglobulin (b2-MG) are usually detected as serological tumor markers (TM) in malignant lymphoproliferative diseases (LPD); however, their use in monitoring of chemotherapy (CT) is limited due to their low sensitivity and specificity. The aim of this paper is to evaluate the prognostic value of baseline levels of thymidine kinase-1 (TK-1) versus b2-MG and LDH in patients with non-Hodgkin\u2019s lymphomas (NHL) and Hodgkin\u2019s lymphoma (HL) and to assess their clinical significance of changes in these parameters during CT as criteria of its effectiveness.\r\nMethods.\u00a0TK-1, b2-MG and LDH levels were evaluated in 61 NHL patients and 34 HL patients at baseline and after each subsequent CT cycle. The average age of patients enrolled in the study was 42.5 years (range 18\u201377 years). Of them 45 were men and 50 were women. Marker levels were determined in serum using the following tests: enzyme-linked immunosorbent assay (ELISA) for TK-1, immunoturbidimetry for b2-MG, and biochemical method for LDH. Discriminatory levels specified by test-system manufacturers were used in calculations: 50 DU\/l for TK-1, 800\u20132400 mg\/l for b2-MG, and 225\u2013450 U\/l for LDH.\r\nResults.\u00a0The study demonstrated that lower baseline levels of all three TM were associated with higher probability of complete or partial remission, and the statistical difference was higher. Baseline levels of TK-1\u00a0&lt;\u00a0150 DU\/l and b2-MG\u00a0&lt;\u00a02200 mg\/l may serve as prognostic factors of higher probability of achievement of complete or partial remission.\r\nConclusion.\u00a04-fold increase in TK-1 serum activity from baseline after the 1st\u00a0course of CT can predict the effectiveness of antitumor therapy. At the same time, no significant associations between b2-MG and LDH serum levels changes during the treatment and efficacy of the treatment were found.<\/jats:p>","DOI":"10.21320\/2500-2139-2016-9-1-6-12","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T20:09:49Z","timestamp":1463861389000},"page":"6-12","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic Significance of Thymidine Kinase-1 versus \u03b22-Microglobulin and Lactate Dehydrogenase in Lymphoproliferative Diseases","\u041f\u0440\u043e\u0433\u043d\u043e\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0435 \u0437\u043d\u0430\u0447\u0435\u043d\u0438\u0435 \u0442\u0438\u043c\u0438\u0434\u0438\u043d\u043a\u0438\u043d\u0430\u0437\u044b-1 \u0432 \u0441\u0440\u0430\u0432\u043d\u0435\u043d\u0438\u0438 \u0441 \u03b22-\u043c\u0438\u043a\u0440\u043e\u0433\u043b\u043e\u0431\u0443\u043b\u0438\u043d\u043e\u043c \u0438 \u043b\u0430\u043a\u0442\u0430\u0442\u0434\u0435\u0433\u0438\u0434\u0440\u043e\u0433\u0435\u043d\u0430\u0437\u043e\u0439 \u043f\u0440\u0438 \u0437\u043b\u043e\u043a\u0430\u0447\u0435\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0445 \u043b\u0438\u043c\u0444\u043e\u043f\u0440\u043e\u043b\u0438\u0444\u0435\u0440\u0430\u0442\u0438\u0432\u043d\u044b\u0445 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f\u0445"],"prefix":"10.21320","volume":"9","author":[{"given":"Natal\u2019ya Konstantinovna","family":"Parilova","sequence":"first","affiliation":[{"name":"P.A. Hertzen Moscow Cancer Research Institute, a branch of the National Medical Research Radiological Center under the Ministry of Health of the Russian Federation, 3 Botkinskii pr-d, Moscow, Russia 125284"},{"name":"\u041c\u043e\u0441\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u043e-\u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0438\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u0438\u043c. \u041f.\u0410. \u0413\u0435\u0440\u0446\u0435\u043d\u0430 \u2014 \u0444\u0438\u043b\u0438\u0430\u043b \u0424\u0413\u0411\u0423 \u00ab\u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0440\u0430\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0446\u0435\u043d\u0442\u0440\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, 2-\u0439 \u0411\u043e\u0442\u043a\u0438\u043d\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 3, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125284"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. S.","family":"Sergeeva","sequence":"additional","affiliation":[{"name":"P.A. Hertzen Moscow Cancer Research Institute, a branch of the National Medical Research Radiological Center under the Ministry of Health of the Russian Federation, 3 Botkinskii pr-d, Moscow, Russia 125284; N.I. Pirogov Russian National Research Medical University under the Ministry of Health of the Russian Federation, 1 Ostrovityanova str., Moscow, Russian Federation, 117997"},{"name":"\u041c\u043e\u0441\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u043e-\u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0438\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u0438\u043c. \u041f.\u0410. \u0413\u0435\u0440\u0446\u0435\u043d\u0430 \u2014 \u0444\u0438\u043b\u0438\u0430\u043b \u0424\u0413\u0411\u0423 \u00ab\u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0440\u0430\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0446\u0435\u043d\u0442\u0440\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, 2-\u0439 \u0411\u043e\u0442\u043a\u0438\u043d\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 3, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125284; \u0413\u0411\u041e\u0423 \u0412\u041f\u041e \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0443\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442 \u0438\u043c. \u041d.\u0418. \u041f\u0438\u0440\u043e\u0433\u043e\u0432\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u0443\u043b. \u041e\u0441\u0442\u0440\u043e\u0432\u0438\u0442\u044f\u043d\u043e\u0432\u0430, \u0434. 1, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 117997"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. V.","family":"Marshutina","sequence":"additional","affiliation":[{"name":"P.A. Hertzen Moscow Cancer Research Institute, a branch of the National Medical Research Radiological Center under the Ministry of Health of the Russian Federation, 3 Botkinskii pr-d, Moscow, Russia 125284"},{"name":"\u041c\u043e\u0441\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u043e-\u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0438\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u0438\u043c. \u041f.\u0410. \u0413\u0435\u0440\u0446\u0435\u043d\u0430 \u2014 \u0444\u0438\u043b\u0438\u0430\u043b \u0424\u0413\u0411\u0423 \u00ab\u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0440\u0430\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0446\u0435\u043d\u0442\u0440\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, 2-\u0439 \u0411\u043e\u0442\u043a\u0438\u043d\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 3, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125284"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. G.","family":"Tyurina","sequence":"additional","affiliation":[{"name":"P.A. Hertzen Moscow Cancer Research Institute, a branch of the National Medical Research Radiological Center under the Ministry of Health of the Russian Federation, 3 Botkinskii pr-d, Moscow, Russia 125284"},{"name":"\u041c\u043e\u0441\u043a\u043e\u0432\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u043e-\u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u043e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0438\u043d\u0441\u0442\u0438\u0442\u0443\u0442 \u0438\u043c. \u041f.\u0410. \u0413\u0435\u0440\u0446\u0435\u043d\u0430 \u2014 \u0444\u0438\u043b\u0438\u0430\u043b \u0424\u0413\u0411\u0423 \u00ab\u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u0440\u0430\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0446\u0435\u043d\u0442\u0440\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, 2-\u0439 \u0411\u043e\u0442\u043a\u0438\u043d\u0441\u043a\u0438\u0439 \u043f\u0440-\u0434, \u0434. 3, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 125284"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. S.","family":"Meisner","sequence":"additional","affiliation":[{"name":"N.I. Pirogov Russian National Research Medical University under the Ministry of Health of the Russian Federation, 1 Ostrovityanova str., Moscow, Russian Federation, 117997"},{"name":"\u0413\u0411\u041e\u0423 \u0412\u041f\u041e \u00ab\u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0439 \u043d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0438\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0443\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442 \u0438\u043c. \u041d.\u0418. \u041f\u0438\u0440\u043e\u0433\u043e\u0432\u0430\u00bb \u041c\u0438\u043d\u0437\u0434\u0440\u0430\u0432\u0430 \u0420\u043e\u0441\u0441\u0438\u0438, \u0443\u043b. \u041e\u0441\u0442\u0440\u043e\u0432\u0438\u0442\u044f\u043d\u043e\u0432\u0430, \u0434. 1, \u041c\u043e\u0441\u043a\u0432\u0430, \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0430\u044f \u0424\u0435\u0434\u0435\u0440\u0430\u0446\u0438\u044f, 117997"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8834","published-online":{"date-parts":[[2016,1,1]]},"reference":[{"key":"16357","unstructured":"\u041f\u0430\u0432\u043b\u043e\u0432\u0430 \u041e.\u0410., \u0422\u044e\u0440\u0438\u043d\u0430 \u041d.\u0413. \u041b\u0438\u043c\u0444\u043e\u043c\u0430 \u0425\u043e\u0434\u0436\u043a\u0438\u043d\u0430. \u041b\u0438\u043c\u0444\u043e\u043f\u0440\u043e\u043b\u0438\u0444\u0435\u0440\u0430\u0442\u0438\u0432\u043d\u044b\u0435 \u043e\u043f\u0443\u0445\u043e\u043b\u0438. \u0412 \u043a\u043d.: \u041e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u044f. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0412.\u0418. \u0427\u0438\u0441\u0441\u043e\u0432\u0430, \u0421.\u041b. \u0414\u0430\u0440\u044c\u044f\u043b\u043e\u0432\u043e\u0439. 2-\u0435 \u0438\u0437\u0434., \u0438\u0441\u043f\u0440. \u0438 \u0434\u043e\u043f. \u041c.: \u0413\u042d\u041e\u0422\u0410\u0420-\u041c\u0435\u0434\u0438\u0430, 2009. \u0421. 829\u201388."},{"key":"16358","unstructured":"[Pavlova OA, Tyurina NG. Hodgkin\u2019s lymphoma. Lymphoproliferative diseases. In Chissov VI, Dar\u2019yalova SL, eds. Onkologiya. Klinicheskie rekomendatsii. (Oncology. Clinical recommendations.) 2nd revised edition. Moscow: GEOTAR-Media Publ.; 2009. p. 829\u201388. (In Russ)]"},{"key":"16359","unstructured":"\u0414\u043e\u043b\u0433\u043e\u0432 \u0412.\u0412., \u041a\u043e\u0437\u043b\u043e\u0432 \u0410.\u0412., \u0420\u0430\u043a\u043e\u0432 \u0421.\u0421. \u041b\u0430\u0431\u043e\u0440\u0430\u0442\u043e\u0440\u043d\u0430\u044f \u044d\u043d\u0437\u0438\u043c\u043e\u043b\u043e\u0433\u0438\u044f. \u041c.: \u0412\u0438\u0442\u0430\u043b \u0414\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0441, 2002. \u0421. 104\u201318."},{"key":"16360","unstructured":"[Dolgov VV, Kozlov AV, Rakov SS. Laboratornaya enzimologiya. (Laboratory methods in enzymology.) Moscow: Vital Diagnostiks Publ.; 2002. p. 104\u201318. (In Russ)]"},{"key":"16361","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2009.02313.x"},{"key":"16362","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402"},{"key":"16363","unstructured":"\u0414\u0430\u0442\u0438 \u0424., \u041c\u0435\u0442\u0446\u043c\u0430\u043d\u043d \u042d. \u0411\u0435\u043b\u043a\u0438. \u041b\u0430\u0431\u043e\u0440\u0430\u0442\u043e\u0440\u043d\u044b\u0435 \u0442\u0435\u0441\u0442\u044b \u0438 \u0438\u0445 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u043e\u0435 \u043f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u0435: \u041f\u0435\u0440. \u0441 \u0430\u043d\u0433\u043b. \u041c.: \u041b\u0430\u0431\u043e\u0440\u0430, 2007. 560 \u0441."},{"key":"16364","unstructured":"[Dati F, Metzman E. Proteins. Laboratory testing and clinical use. Holzheim; 2005. (Russ. ed.: Dati F, Metzman E. Belki. Laboratornye testy i ikh klinicheskoe primenenie. Moscow: Labora Publ.; 2007. 560 p.)]"},{"key":"16365","unstructured":"Votava T, Topolcan O, Holubec L Jr, et al. Changes of serum thymidine kinase in children with acute leukemia. Anticancer Res. 2007;27(4A):1925\u20138."},{"key":"16366","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2013.149"},{"key":"16367","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-010-0067-4"},{"key":"16368","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-010-0769-z"},{"key":"16369","unstructured":"\u041f\u0430\u0440\u0438\u043b\u043e\u0432\u0430 \u041d.\u041a., \u0421\u0435\u0440\u0433\u0435\u0435\u0432\u0430 \u041d.\u0421., \u0422\u044e\u0440\u0438\u043d\u0430 \u041d.\u0413. \u0438 \u0434\u0440. \u0421\u044b\u0432\u043e\u0440\u043e\u0442\u043e\u0447\u043d\u044b\u0435 \u0443\u0440\u043e\u0432\u043d\u0438 \u0442\u0438\u043c\u0438\u0434\u0438\u043d\u043a\u0438\u043d\u0430\u0437\u044b-1 (\u0422\u041a-1) \u0443 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0441 \u043b\u0438\u043c\u0444\u043e\u043f\u0440\u043e\u043b\u0438\u0444\u0435\u0440\u0430\u0442\u0438\u0432\u043d\u044b\u043c\u0438 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f\u043c\u0438. \u041e\u043d\u043a\u043e\u043b\u043e\u0433\u0438\u044f. \u0416\u0443\u0440\u043d\u0430\u043b \u0438\u043c. \u041f.\u0410. \u0413\u0435\u0440\u0446\u0435\u043d\u0430. 2012;1:33\u20138."},{"key":"16370","unstructured":"[Parilova NK, Sergeeva NS, Tyurina NG, et al. Serum thymidine kinase 1 (TK-1) levels in patients with lymphoproliferative disorders. Onkologiya. Zhurnal im PA Gertsena. 2012;1:33\u20138. (In Russ)]"},{"key":"16371","unstructured":"Bogni A, Cortinois A, Grasseli G, et al. Thymidine kinase (TK) activity as a prognostic parameter of survival in lymphoma patients. J Biol Regul Homeost Agents. 1994;8(4):10."},{"key":"16372","doi-asserted-by":"crossref","unstructured":"Nisman B, Nechushtan H, Biran H, et al. Serum thymidine kinase 1 activity in the prognosis and monitoring of chemotherapy in lung cancer patients: a brief report. J Thorac Oncol. 2014;9(10):1568\u201372. doi: 10.1097\/jto.0000000000000276.","DOI":"10.1097\/JTO.0000000000000276"},{"key":"16373","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000276"}],"container-title":["Clinical Oncohematology"],"original-title":[],"link":[{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/462\/427","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/462\/427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T11:29:46Z","timestamp":1764502186000},"score":1,"resource":{"primary":{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/view\/462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.21320\/2500-2139-2016-9-1-6-12","relation":{},"ISSN":["2500-2139","1997-6933"],"issn-type":[{"value":"2500-2139","type":"electronic"},{"value":"1997-6933","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,1]]}}}